Petros Pharmaceuticals, Inc. Cash
Petros Pharmaceuticals, Inc. (PTPI) had Cash of $3.89 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2024-11-13
- 2024-09-30: Cash $3.89M.
- 2024-06-30: Cash $7.46M.
- 2024-03-31: Cash $11.08M.
- 2023-12-31: Cash $13.34M.
| Period end | Cash |
|---|---|
| 2024-09-30 | $3.89M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $7.46M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.08M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $13.34M 10-Q · filed 2024-11-13 |
| 2023-09-30 | $17.97M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $7.38M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.32M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.43M 10-K · filed 2024-04-01 |
| 2022-09-30 | $11.18M 10-Q/A · filed 2022-11-15 |
| 2021-12-31 | $23.85M 10-Q/A · filed 2022-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |